| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenues | $10.98B+13.2% | $9.70B+4.4% | $9.29B+13.8% | $8.16B+7.2% | $7.61B+39.4% | $5.46B |
| Cost of sales | $10.77B+13.0% | $9.53B+5.9% | $8.99B+13.9% | $7.90B+6.7% | $7.40B+37.2% | $5.39B |
| Gross profit | $210.9M+21.7% | $173.3M-41.2% | $294.7M+12.6% | $261.8M+24.5% | $210.2M+213.9% | $67.0M |
| Selling, general, and administrative expenses | -$139.2M-55.0% | -$89.8M-5.3% | -$85.3M-11.3% | -$76.6M-59.6% | -$48.0M-30.6% | -$36.8M |
| Depreciation and amortization expense | -$22.9M-101.1% | -$11.4M+9.0% | -$12.5M+54.1% | -$27.3M-153.0% | -$10.8M | — |
| Interest income | $25.9M-4.5% | $27.2M+22.2% | $22.2M+2.0% | $21.8M+18.0% | $18.5M-13.0% | $21.2M |
| Interest expense | -$46.2M-16.9% | -$39.5M-25.4% | -$31.5M-43.4% | -$22.0M-10.7% | -$19.9M-5.3% | -$18.9M |
| (Losses) Earnings from equity method investments | -$2.8M-169.9% | $4.0M-67.8% | $12.6M+82.1% | $6.9M-55.6% | $15.5M+218.7% | $4.9M |
| Other income, net | $2.0M-1.9% | $2.1M-22.2% | $2.7M+36.4% | $2.0M+81.0% | $1.1M+210.1% | $348K |
| Remeasurement (loss) gain on pre-existing equity interests | -$5.1M-130.9% | $16.7M | $0 | — | — | — |
| Unrealized (losses) gains on foreign exchange | -$1.3M-548.5% | $299K-18.3% | $366K+473.5% | -$98K+24.0% | -$129K-326.3% | $57K |
| Net income before provision for income taxes | $21.3M-74.3% | $82.8M-59.3% | $203.2M+22.1% | $166.4M-13.7% | $192.8M+409.0% | $37.9M |
| Income tax expense | -$5.4M+60.5% | -$13.7M+70.4% | -$46.4M-39.2% | -$33.3M-4.6% | -$31.9M-399.1% | -$6.4M |
| Net income | $15.8M-77.0% | $69.0M-56.0% | $156.8M+17.8% | $133.1M-17.3% | $160.9M+411.0% | $31.5M |
| Net (loss) income attributable to noncontrolling interests | -$1.5M-403.1% | $487K+19.1% | $409K-24.7% | $543K-57.8% | $1.3M+31.1% | $982K |
| Net income attributable to the Company | $17.3M-74.7% | $68.5M-56.2% | $156.4M+18.0% | $132.5M-17.0% | $159.6M+423.2% | $30.5M |
| Basic | $23.63B+2.3% | $23.09B-1.3% | $23.40B+2.6% | $22.81B+36.7% | $16.69B+237212.1% | $7.0M |
| Diluted | $24.44B+1.3% | $24.12B-2.1% | $24.65B+1.3% | $24.33B+35.6% | $17.94B+253336.9% | $7.1M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.